You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Invasive Lobular Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))

Not yet recruiting
  • Carcinoma, Lobular
  • [18F]fluoroestradiol (FES)
  • (no location specified)
Jul 18, 2023

Invasive Lobular Breast Carcinoma Trial in Salt Lake City ([18F]Fluoroestradiol (FES) PET/CT)

Recruiting
  • Invasive Lobular Breast Carcinoma
  • [18F]Fluoroestradiol (FES) PET/CT
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 14, 2022

Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

Recruiting
  • Invasive Lobular Breast Carcinoma
  • +2 more
  • Brussels, Belgium
  • +9 more
May 4, 2022

Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,

Recruiting
  • Metastatic Cancer
  • +2 more
  • Madison, Wisconsin
    UW Carbone Cancer Center
Oct 10, 2023

Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

Not yet recruiting
  • Anatomic Stage I Breast Cancer
  • +3 more
  • Endocrine Therapy
  • +7 more
  • Atlanta, Georgia
  • +4 more
Jun 15, 2023

Breast Cancer Trial in United States (Letrozole, Tamoxifen, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Stamford, Connecticut
  • +10 more
Jul 15, 2022

Molecular Analysis of the Sloane Project

Enrolling by invitation
  • DCIS
  • +3 more
    • London, United Kingdom
      King's College London
    May 11, 2023

    Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

    Completed
    Has Results
    • Breast Atypical Ductal Hyperplasia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

    Active, not recruiting
    • Breast Cancer
    • +4 more
    • External Beam Radiation Therapy
    • +2 more
    • Richmond, Virginia
    • +1 more
    Dec 16, 2022

    Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

    Recruiting
    • Invasive Ductal Breast Carcinoma
    • +14 more
    • Stereotactic body radiotherapy
    • Lattice Radiation Therapy
    • Basking Ridge, New Jersey
    • +6 more
    Apr 20, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Computed Tomography
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 9, 2022

    Treating Patients With Stage IV Breast Cancer

    Active, not recruiting
    • Central Nervous System Metastases
    • +15 more
    • hyperfractionated radiation therapy
    • +2 more
    • North Chicago, Illinois
      University of Chicago
    Dec 6, 2021

    Molecular Genetic Basis of Invasive Breast Cancer Risk

    Completed
    • Breast Cancer
    • +2 more
    • Tissue specimen
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 30, 2021

    Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

    Recruiting
    • Pleomorphic Lobular Breast Carcinoma in Situ
    • Breast Florid Lobular Carcinoma in Situ
    • Surgical wide local excision
    • +4 more
    • Padova, Italy
      Istituto Oncologico Veneto IRCCS
    Nov 14, 2023

    Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

    Active, not recruiting
    • Inflammatory Breast Cancer
    • +9 more
    • External beam radiation therapy
    • New Brunswick, New Jersey
    • +1 more
    Jan 30, 2022

    Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ Trial in Boston (Naltrexone, Sugar

    Terminated
    Has Results
    • Invasive Breast Cancer (Stage I-III)
    • +4 more
    • Boston, Massachusetts
    • +1 more
    Nov 12, 2021

    Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

    Not yet recruiting
    • Breast Cancer Female
    • +4 more
    • (no location specified)
    Aug 8, 2023

    Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Ductal Carcinoma Trial in Philadelphia (Indocyanine Green)

    Completed
    • Invasive Ductal Carcinoma
    • +2 more
    • Indocyanine Green
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jan 26, 2021

    Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Lobular Breast Carcinoma
    • Blood Specimen
    • San Francisco, California
      University of California, San Francisco
    Jul 19, 2023

    Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

    Not yet recruiting
    • Lobular Breast Carcinoma
    • 68Ga-FAPI-46 PET scan
    • Monaco, Monaco
      Centre Hospitalier Princesse Grace
    Jun 27, 2023

    Searching for Novel Germline Mutations in Lobular Breast Cancer

    Recruiting
    • Lobular Breast Carcinoma
    • +3 more
    • Illumina panel
    • Milan, Italy
      European Institute of Oncology
    Sep 12, 2022

    Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston

    Completed
    Has Results
    • Benign Breast Neoplasm
    • +11 more
    • Docosahexaenoic Acid
    • Placebo
    • Boston, Massachusetts
    • +3 more
    Dec 3, 2021

    Invasive Ductal and Invasive Lobular Breast Carcinoma, Stage 0 Breast Carcinoma, Stage I Breast Carcinoma Trial in Orange

    Active, not recruiting
    • Invasive Ductal and Invasive Lobular Breast Carcinoma
    • +3 more
    • Intraoperative Radiotherapy
    • Orange, California
      St. Joseph Hospital of Orange
    Mar 30, 2021

    Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

    Recruiting
    • Atypical Hyperplasia
    • Lobular Carcinoma in Situ
    • Evanston, Illinois
    • +1 more
    Jan 20, 2023

    CDH1 Germline Mutations in Lobular Breast Cancer

    Active, not recruiting
    • Lobular Breast Carcinoma
    • CDH1 Gene Inactivation
      • Milan, Italy
        European Institute of Oncology
      Jan 11, 2022